Mechanistic studies reveal that METTL14 enhances SETBP1 mRNA m6A modification by forming a heterodimer with METTL3, increasing SETBP1 mRNA stability, and activating the PI3K‐AKT signaling pathway, thereby promoting MDS development.275. Here, SETBP1 is linked to myelodysplastic syndrome.